Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.16 - $23.33 $1,216 - $2,333
100 Added 0.13%
74,300 $1.69 Million
Q2 2024

Aug 15, 2024

SELL
$11.6 - $17.26 $105,560 - $157,066
-9,100 Reduced 10.92%
74,200 $965,000
Q1 2024

May 07, 2024

BUY
$17.09 - $23.82 $991,220 - $1.38 Million
58,000 Added 229.25%
83,300 $1.46 Million
Q4 2023

Feb 14, 2024

BUY
$11.12 - $22.5 $281,336 - $569,250
25,300 New
25,300 $551,000
Q2 2023

Aug 11, 2023

BUY
$22.57 - $29.67 $584,563 - $768,453
25,900 Added 49.71%
78,000 $1.86 Million
Q1 2023

May 16, 2023

BUY
$25.04 - $37.6 $182,792 - $274,480
7,300 Added 16.29%
52,100 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$18.78 - $29.74 $39,438 - $62,454
2,100 Added 4.92%
44,800 $1.31 Million
Q3 2022

Nov 14, 2022

BUY
$10.7 - $25.5 $116,629 - $277,950
10,900 Added 34.28%
42,700 $876,000
Q2 2022

Aug 15, 2022

SELL
$9.55 - $19.0 $67,805 - $134,900
-7,100 Reduced 18.25%
31,800 $368,000
Q1 2022

May 16, 2022

BUY
$16.79 - $20.88 $188,048 - $233,856
11,200 Added 40.43%
38,900 $719,000
Q4 2021

Feb 14, 2022

BUY
$15.65 - $21.5 $164,325 - $225,750
10,500 Added 61.05%
27,700 $548,000
Q3 2021

Nov 15, 2021

BUY
$10.69 - $18.2 $183,868 - $313,040
17,200 New
17,200 $283,000

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $803M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.